@khurramn1 @drjohnm @MichaelJBlaha @rblument1 @BudoffMd @DrRumberger @drmikefarkouh @DrMarthaGulati @MBittencourtMD Neither the coronary arteries of the older patients with zero CAC enrolled in the Bioimage study...👇🏽 https://t.co/DsiMepTCpV
“Interestingly, galectin-3 <25th percentile performed as well or better than assessment of subclinical #atherosclerosis by carotid ultrasound. These novel data indicate that galectin-3 may be a clinically useful negative risk marker for ASCVD derisking.
RT @igormorr: To limit overtreatment, elderly individuals at truly low risk need to be identified. https://t.co/OQNsoVCGvi
RT @igormorr: To limit overtreatment, elderly individuals at truly low risk need to be identified. https://t.co/OQNsoVCGvi
RT @JACCJournals: Which of the following findings do you think could warrant removing your elderly patients off of a statin despite elevate…
RT @JACCJournals: Which of the following findings do you think could warrant removing your elderly patients off of a statin despite elevate…
Which of the following findings do you think could warrant removing your elderly patients off of a statin despite elevated #CVD risk by the pooled cohort equations? Learn more about negative risk markers for CV events in the elderly in #JACC. https://t.c
Gal-3 is a new CV risk factor. Possibly more helpful as a negative risk factor than other biomarkers.
To limit overtreatment, elderly individuals at truly low risk need to be identified. https://t.co/OQNsoVCGvi
RT @G3Pharma: Another novel and authoritative contribution to our understanding of #galectin3 and CVD: Low Gal-3 was the strongest blood b…
Another novel and authoritative contribution to our understanding of #galectin3 and CVD: Low Gal-3 was the strongest blood biomarker of low CHD and CVD risks. In animal models we can block Gal-3 and human testing may only be several years away. https:/
Negative Risk Markers for Cardiovascular Events in the Elderly. https://t.co/8bIgYYv2w9
Elderly patients and CVDs #JACC: Despite elevated CVD risk, should elderly patients with no or very low CAD, no carotid plaque or low galectin-3 levels come off their statins? New research examines who might be a “low-risk elderly” patient. https://t.co/ZH
RT @JACCJournals: Should certain clinical variables let the elderly off the hook when it comes to statins? New #JACC Original Investigation…
RT @JACCJournals: Should certain clinical variables let the elderly off the hook when it comes to statins? New #JACC Original Investigation…
RT @JACCJournals: Should certain clinical variables let the elderly off the hook when it comes to statins? New #JACC Original Investigation…
RT @JACCJournals: Should certain clinical variables let the elderly off the hook when it comes to statins? New #JACC Original Investigation…
RT @JACCJournals: Should certain clinical variables let the elderly off the hook when it comes to statins? New #JACC Original Investigation…
Should certain clinical variables let the elderly off the hook when it comes to statins? New #JACC Original Investigation introduces negative risk markers for CV events in the elderly. https://t.co/JdQqPUMQB4 @AUHdk https://t.co/YmnopFxUsG
Beats all other risk models.
RT @DrDerekConnolly: In primary prevention of cardiovascular events, having a CT calcium score of 0 is the best predictive “negative risk f…
RT @KoushikReddyMD: Finding Zero https://t.co/CPfwHC8EnH
Negative Risk Markers for Cardiovascular Events in the Elderly https://t.co/E1B1NYx5sg
"Elderly individuals with CAC = 0, CAC ≤10, low galectin-3, or no carotid plaque had remarkable low cardiovascular risk, calling into question the appropriateness of a treat-all approach in the elderly population." https://t.co/yh4Go0Okeq https://t.co/Wk
Negative Risk Markers for Cardiovascular Events in the Elderly https://t.co/Xha9GKSEk4
Finding Zero https://t.co/CPfwHC8EnH